Jian Chen

Dr. Jian Chen

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 June 2025 in Journal for ImmunoTherapy of Cancer
Verified
Journal Article
Open access
PDF file
HYHong Yang
Hong Yang
BDBoshao Deng
Boshao Deng
XHXiao Han
Xiao Han
LWLulu Wang
Lulu Wang
JZJing Zhao
Jing Zhao
JCJian Chen
Jian Chen
Background Breast cancer is the most diagnosed malignancy and a leading cause of cancer-related deaths among women globally. Cuproptosis plays a significant role in tumor progression and therapeutic response. Increasing studies suggest that targeting cuproptosis presents a promising strategy for cancer therapy, such as through the development of copper nanoparticles as therapeutic agents. However, resistance to cuproptosis has emerged as a critical hallmark of cancer. Therefore, it is essential to further investigate the mechanisms underlying cuproptosis resistance to enhance its therapy effect. Methods The relationship between breast cancer progression and the C5a/C5aR pathway or cuproptosis was determined by single-cell RNA sequencing analyses, RNA-sequence analyses, bioinformatic analyses, survival analyses and immunohistochemistry. The antitumor effects of CuS nanoparticles and C5a receptor antagonists (C5aRA) were assessed by in vitro and in vivo strategies including cell counting kit-8, colony formation assay, relative reactive oxygen species level assay, western blots, real-time quantitative PCR, immunohistochemistry, immunofluorescence assay, flow cytometry and the xenograft mice models. Complement system activation by CuS nanoparticles was tested by ELISA. Results Our results indicated that activation of the C5a/C5aR pathway contributes to cuproptosis resistance by upregulating ATP7B expression via the Wnt/β-catenin pathway. Consequently, combining CuS nanoparticles with lazer treatment and C5aRA markedly enhanced the antitumor efficacy of CuS nanoparticles by overcoming cuproptosis resistance, leading to a synergistic effect in cancer therapy that included cuproptosis-targeting therapy, immunotherapy, and photothermal therapy. Conclusions This study reports, for the first time, proved C5a/C5aR pathway-mediated cuproptosis resistance in cancer cells, and combining CuS nanoparticles and C5aRA offers a superior and novel therapeutic strategy for cancer.

17 October 2024 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
HYHong Yang
Hong Yang
GLGuiqing Li
Guiqing Li
JZJi Zhang
Ji Zhang
JZJing Zhao
Jing Zhao
YZYunpei Zhao
Yunpei Zhao
JCJian Chen
Jian Chen
Breast cancer is the most diagnosed malignancy and major cause of cancer death among women population in the worldwide. Ferroptosis is a recently discovered iron-dependent regulated cell death involved in tumor progression and therapeutic response. Moreover, increasing studies have implied that ferroptosis is a promising approach to eliminating cancer cells like developing iron nanoparticles as a therapeutic agent. However, resistance to ferroptosis is a vital distinctive hallmark of cancer. Therefore, further investigation of the mechanism of ferroptosis resistance to enhance its tumor sensitivity is essential for ferroptosis-target breast cancer therapy. Our results revealed that the activation of C5a/C5aR pathway can drive resistance to ferroptosis and reshaping breast cancer immune microenvironment. Accordingly, loading PEG-Fe3O4 with C5aRA significantly improved the anti-tumor effect of PEG- Fe3O4 by inhibiting ferroptosis resistance and increasing macrophage polarization toward M1 phenotype. Our findings presented a novel cancer therapy strategy that combined cancer cell metal metabolism regulation and immunotherapy. The study also provided support for further evaluation of PEG- Fe3O4@C5aRA as a novel therapeutic strategy for breast cancer in clinical trials.

1 October 2014
Verified
Conference Paper
Closed access
AJAnfeng Jiang
Anfeng Jiang
ZFZhengcai Fu
Zhengcai Fu
WSWei Sun
Wei Sun
JCJian Chen
Jian Chen
GWGuoli Wang
Guoli Wang
RLRuihai Li
Ruihai Li
The multiple lightning strokes are the main cause of distribution arresters failures. In order to evaluate performance of distribution lines arresters more realistically, the experimental and analytical studies of the effects of multiple lightning impulse currents on metal-oxide arrester blocks are carried out. The multiple impulse current generator developed by Shanghai Jiao Tong University is adopted, the generator could output four impulse current representing one first stroke current, two subsequent stroke current and one continuing current of interval stroke, respectively. The variable interval time between the two impulses could achieve as low as 1 ms. The effects of block dimension, interval time between impulse currents, the sequences of impulse currents and the amplitude of impulse currents are studied. The results show larger amplitude of multiple impulse current, less interval time between impulse currents and smaller geometric parameter of arrester block are the causes of blocks failure. Surface flashover and energy absorption are two failure characteristics under multiple impulse current. The DC 1mA reference voltage is more sensitive than the residual voltage of blocks under multiple impulse current. The multiple impulse currents tests are suitable for performance evaluation of distribution lines arresters under natural lightning stroke.

15 April 2026 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
GLGuokang Liu
Guokang Liu
BDBoshao Deng
Boshao Deng
XHXiao Han
Xiao Han
YZYunpei Zhao
Yunpei Zhao
SZShiyu Zeng
Shiyu Zeng
JCJian Chen
Jian Chen
Alzheimer’s disease (AD) is a multifactorial neurodegenerative disorder in which synaptic loss is closely associated with cognitive decline. Although the amyloid hypothesis has long dominated AD research, the limited efficacy of amyloid-targeted therapies highlights the need to explore additional pathogenic mechanisms. Increasing evidence indicates that dysregulation of the complement system plays a critical role in AD, linking genetic risk, protein aggregation, neuroinflammation, and neurodegeneration. Under physiological conditions, complement signaling is essential for neural development and synaptic refinement; however, in AD, aberrant activation contributes to excessive synaptic pruning and sustained inflammatory responses. As a result, complement components have attracted attention as potential biomarkers and therapeutic targets, despite limitations in disease specificity. This review summarizes current advances in understanding complement system alterations in AD, discusses their roles in disease pathogenesis, and highlights emerging complement-targeted therapeutic strategies, as well as remaining challenges related to intervention timing, patient stratification, and blood–brain barrier delivery.

9 January 2025 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
QNQinxue Ni
Qinxue Ni
HYHong Yang
Hong Yang
HRHang Rao
Hang Rao
LZLiyong Zhang
Liyong Zhang
MXMengyuan Xiong
Mengyuan Xiong
YSYan Shi
Yan Shi
Gastric cancer continues to be a leading global health concern, with current therapeutic approaches requiring significant improvement. While the disruption of iron metabolism in the advancement of gastric cancer has been well-documented, the underlying regulatory mechanisms remain largely unexplored. Additionally, the complement C5a-C5aR pathway has been identified as a crucial factor in gastric cancer development. The impact of the complement system on iron metabolism and its role in gastric cancer progression is an area warranting further investigation. Our research demonstrates that the C5a-C5aR pathway promotes gastric cancer progression by enhancing iron acquisition in tumor cells through two mechanisms. First, it drives macrophage polarization toward the M2 phenotype, which has a strong iron-release capability. Second, it increases the expression of LCN2, a high-affinity iron-binding protein critical for iron export from tumor-associated macrophages, by activating endoplasmic reticulum stress in these cells. Both mechanisms facilitate the transfer of iron from macrophages to cancer cells, thereby promoting tumor cell proliferation. This study aims to elucidate the connection between the complement C5a-C5aR pathway and iron metabolism within the tumor microenvironment. Our data suggest a pivotal role of the C5a-C5aR pathway in tumor iron management, indicating that targeting its regulatory mechanisms may pave the way for future iron-targeted therapeutic approaches in cancer treatment.

7 June 2014 in Journal of Biomedical Materials Research Part A
Verified
Journal Article
Closed access
PDF file
YYYanzhu Yang
Yanzhu Yang
SSSanyuan Shi
Sanyuan Shi
QDQian Ding
Qian Ding
JCJian Chen
Jian Chen
JPJinliang Peng
Jinliang Peng
YXYuhong Xu
Yuhong Xu